Clonidine/ketorolac/ropivacaine Interactions
There are 877 drugs known to interact with clonidine/ketorolac/ropivacaine, along with 16 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 169 are major, 630 are moderate, and 78 are minor.
- View all 877 medications that may interact with clonidine/ketorolac/ropivacaine
- View clonidine/ketorolac/ropivacaine alcohol/food interactions (4)
- View clonidine/ketorolac/ropivacaine disease interactions (16)
Most frequently checked interactions
View interaction reports for clonidine / ketorolac / ropivacaine and the medicines listed below.
- Abilify (aripiprazole)
- Arcalyst (rilonacept)
- Caplyta (lumateperone)
- Concerta (methylphenidate)
- Contrave (bupropion / naltrexone)
- Cymbalta (duloxetine)
- Dayvigo (lemborexant)
- L-Carnitine (levocarnitine)
- Lamictal (lamotrigine)
- Latuda (lurasidone)
- Morphine Sulfate IR (morphine)
- Phenergan (promethazine)
- Pristiq (desvenlafaxine)
- Remeron (mirtazapine)
- Risperdal (risperidone)
- Ritalin (methylphenidate)
- Seroquel (quetiapine)
- Seroquel XR (quetiapine)
- Voltaren Arthritis Pain Gel (diclofenac topical)
- Vyvanse (lisdexamfetamine)
- Zyprexa (olanzapine)
Clonidine/ketorolac/ropivacaine alcohol/food interactions
There are 4 alcohol/food interactions with clonidine / ketorolac / ropivacaine.
Clonidine/ketorolac/ropivacaine disease interactions
There are 16 disease interactions with clonidine / ketorolac / ropivacaine which include:
- GI toxicity
- platelet aggregation inhibition
- renal dysfunction
- asthma
- fluid retention
- GI toxicity
- rash
- thrombosis
- bradyarrhythmia
- depression
- hypotension
- renal dysfunction
- sedatives/alcohol
- anemia
- hepatotoxicity
- hyperkalemia
Report options
QR code containing a link to this page
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.